Chromium (Cr) is a naturally occurring element whose nutritional bioavailability and toxicity depends on its oxidation state. Trivalent chromium is considered an essential nutrient while hexavalent chromium is a human carcinogen and a commonly encountered occupational hazard for humans (Anderson 1989, ATSDR 2000). Cobalt (Co) is considered essential because it is part of the B12 vitamin, which is important for the human brain and nervous center functioning and cell metabolism (ATSDR 2000, Burtis et. al., 2012). While it is essential at certain lower levels, exposures to high levels of cobalt can affect the heart and/or lungs. Elevated exposures in animals have been shown to affect the liver and kidneys. The Agency for Toxic Substances and Disease Registry (ATSDR) lists cobalt as a possible carcinogen to animals due to research performed by the International Agency for Research on Cancer where direct contact with cobalt occurred (ATSRD 2000). It is uncertain whether or not the effects seen in animals will also be seen in humans, and this uncertainty adds additional concerns with a problem seen with failed metal-on-metal (MoM) hip implants.
Examined participants aged 40 years and older were eligible.
The concentrations of chromium (52Cr) and cobalt (59Co) in whole blood specimens are directly measured using inductively coupled plasma mass spectrometry (ICP-MS). This analytical technique is based on analyte detection using quadrupole ICP-MS technology, including Kinetic Energy Discrimination (KED) technology which minimizes or eliminates many argon-based polyatomic interferences. Although it is unnecessary to measure cobalt in KED mode, both cobalt and chromium are measured in KED mode to reduce the stabilization time between modes (Sampson et. al., 2012). The sample goes through a nebulizer where it is converted into aerosol upon entering the spray chamber. Carried by a stream of argon gas, a portion of the aerosol is transported through the spray chamber and then through the central channel of the plasma where it is heated to temperatures of approximately 6000-8000°K. This thermal energy atomizes and ionizes the sample. The ions and the argon enter the mass spectrometer through an interface that separates the ICP (operating at atmospheric pressure of approximately 760 torr), from the mass spectrometer (operating at approximately 10-5 torr). Once inside the mass spectrometer, the ions pass through the ion optics, which uses an electrical field to focus the ion beam into the collision cell (QCell™). The QCell™ is pressurized with an appropriate reaction gas (in this case helium) and contains a flatapole quadrupole system. Elimination or reduction of argon-based polyatomic interferences takes place through the interaction of the reaction gas with the interfering polyatomic species in the incoming ion beam. The ions go from the collision cell to the mass-analyzing quadrupole before striking the surface of the detector. Once ions pass through the cell and are electrically selected for passage through the analytical quadrupole, electrical signals resulting from the ions striking the detector are processed into digital information that is used to indicate the intensity of the ions. The intensity of ions detected while aspirating an unknown sample is translated into an elemental concentration through comparison of the analyte to internal standard signal ratio of the unknown with the ratio obtained when aspirating calibration standards. This method is a variation of IRAT’s method used to analyze lead, cadmium, mercury, manganese, and selenium in whole blood, which was originally based on the method by Lutz et. al.
Refer to the Laboratory Method Files section for a detailed description of the laboratory methods used.
There we no changes to the lab method, lab equipment, or lab site for this component in the NHANES 2017-2018 cycle.
Chromium and Cobalt (June 2020)
Whole blood specimens were processed, stored, and shipped to the Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA for analysis.
Detailed instructions on specimen collection and processing are discussed in the NHANES Laboratory Procedures Manual (LPM). Vials are stored under appropriate frozen (-30°C) conditions until they are shipped to National Center for Environmental Health for testing.
The NHANES quality assurance and quality control (QA/QC) protocols meet the 1988 Clinical Laboratory Improvement Act mandates. Detailed QA/QC instructions are discussed in the NHANES LPM.
Mobile Examination Centers (MECs)
Laboratory team performance is monitored using several techniques. NCHS and contract consultants use a structured competency assessment evaluation during visits to evaluate both the quality of the laboratory work and the quality-control procedures. Each laboratory staff member is observed for equipment operation, specimen collection and preparation; testing procedures and constructive feedback are given to each staff member. Formal retraining sessions are conducted annually to ensure that required skill levels were maintained.
Analytical Laboratories
NHANES uses several methods to monitor the quality of the analyses performed by the contract laboratories. In the MEC, these methods include performing blind split samples collected on “dry run” sessions. In addition, contract laboratories randomly perform repeat testing on 2% of all specimens.
NCHS developed and distributed a quality control protocol for all CDC and contract laboratories, which outlined the use of Westgard rules (Westgard et al., 1981) when running NHANES specimens. Progress reports containing any problems encountered during shipping or receipt of specimens, summary statistics for each control pool, QC graphs, instrument calibration, reagents, and any special considerations are submitted to NCHS quarterly. The reports are reviewed for trends or shifts in the data. The laboratories are required to explain any identified areas of concern.
All QC procedures recommended by the manufacturers were followed. Reported results for all assays meet the Division of Environmental Health Laboratory Sciences’ quality control and quality assurance performance criteria for accuracy and precision, similar to the Westgard rules (Caudill, et al., 2008).
The data were reviewed. Incomplete data or improbable values were sent to the performing laboratory for confirmation.
Two variables were created in this data file. The variables were created using the following formulas:
LBDBCRSI: The chromium value in ug/L (LBXBCR) was converted to nmol/L (LBDCRSI) by multiplying LBXBCR by 19.23 (rounded to 2 decimal points).
LBDBCOSI: The cobalt value in ug/L (LBXBCO) was converted to nmol/L (LBDCOSI) by multiplying LBXBCO by 16.97 (rounded to 2 decimal points).
Refer to the 2017 - 2018 Laboratory Data Overview for general information on NHANES laboratory data.
There are over 800 laboratory tests performed on NHANES participants. However, not all participants provided biospecimens or enough volume for all the tests to be performed. The specimen availability can also vary by age or other population characteristics. For example, in 2017-2018, approximately 80% of children aged 1-17 years who were examined in the MEC provided a blood specimen through phlebotomy, while 95% of examined adults age 18 and older provided a blood specimen. Analysts should evaluate the extent of missing data in the dataset related to the outcome of interest as well as any predictor variables used in the analyses to determine whether additional re-weighting for item non-response is necessary.
Please refer to the NHANES Analytic Guidelines and the on-line NHANES Tutorial for further details on the use of sample weights and other analytic issues.
Demographic and Other Related Variables
The analysis of NHANES laboratory data must be conducted using the appropriate survey design and demographic variables. The NHANES 2017-2018 Demographics File contains demographic data, health indicators, and other related information collected during household interviews as well as the sample design variables. The recommended procedure for variance estimation requires use of stratum and PSU variables (SDMVSTRA and SDMVPSU, respectively) in the demographic data file.
The Fasting Questionnaire File includes auxiliary information, such as fasting status, length of fast, and the time of venipuncture.
This laboratory data file can be linked to the other NHANES data files using the unique survey participant identifier (i.e., SEQN).
Detection Limits
The detection limits were constant for all of the analytes in the data set. Two variables are provided for each of these analytes. The variable name ending in “LC” (ex., LBXBCRLC) indicates whether the result was below the limit of detection: the value “0” means that the result was at or above the limit of detection, “1” indicates that the result was below the limit of detection. The other variable prefixed LBX (ex., LBXBCR) provides the analytic result for that analyte. For analytes with analytic results below the lower limit of detection (ex., LBXBCRLC=1), an imputed fill value was placed in the analyte results field. This value is the lower limit of detection divided by the square root of 2 (LLOD/sqrt[2]).
The lower limit of detection (LLOD) in µg/L for Chromium and Cobalt:
|
Variable Name |
Analyte Description |
LLOD |
|
LBXBCR |
Chromium |
0.41 µg/L |
|
LBXBCO |
Cobalt |
0.06 µg/L |
| Code or Value | Value Description | Count | Cumulative | Skip to Item |
|---|---|---|---|---|
| 0.29 to 8.62 | Range of Values | 3518 | 3518 | |
| . | Missing | 158 | 3676 |
| Code or Value | Value Description | Count | Cumulative | Skip to Item |
|---|---|---|---|---|
| 5.58 to 165.76 | Range of Values | 3518 | 3518 | |
| . | Missing | 158 | 3676 |
| Code or Value | Value Description | Count | Cumulative | Skip to Item |
|---|---|---|---|---|
| 0 | At or above the detection limit | 428 | 428 | |
| 1 | Below lower detection limit | 3090 | 3518 | |
| . | Missing | 158 | 3676 |
| Code or Value | Value Description | Count | Cumulative | Skip to Item |
|---|---|---|---|---|
| 0.04 to 17.79 | Range of Values | 3520 | 3520 | |
| . | Missing | 156 | 3676 |
| Code or Value | Value Description | Count | Cumulative | Skip to Item |
|---|---|---|---|---|
| 0.68 to 301.9 | Range of Values | 3520 | 3520 | |
| . | Missing | 156 | 3676 |
| Code or Value | Value Description | Count | Cumulative | Skip to Item |
|---|---|---|---|---|
| 0 | At or above the detection limit | 3490 | 3490 | |
| 1 | Below lower detection limit | 30 | 3520 | |
| . | Missing | 156 | 3676 |